Skip to main content

Epizyme, Inc.

EPZMDelisted Aug 12, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001571498

Epizyme, Inc. was delisted on Aug 12, 2022; its insiders filed their last Form 4 on Aug 16, 2022; 94 institutions reported holding it in 13F filings for Q2 2022, worth $187.0M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Epizyme, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of EPZM: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders127116−11
Shares95.1M93.7M−1.41M (−1.5%)
Value$790.2M$479.9M−$310.3M (−39.3%)

New holders (11)

Institutions that held Epizyme, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to EPZM in Q3 2021
InstitutionSharesValue% of portfolio
Platinum Investment Management Ltd1,903,893$9.75M0.27%
Gsa Capital Partners LLP71,652$367.0K0.04%
SG Americas Securities, LLC40,286$206.0K0.00%
Prudential Financial Inc37,315$191.0K0.00%
Sage Mountain Advisors LLC24,273$124.0K0.02%
E Fund Management Co., Ltd.13,338$68.0K0.00%
Virginia Retirement Systems Et Al11,900$61.0K0.00%
Two Sigma Investments, LP12,000$61.0K0.00%
Teacher Retirement System of Texas11,469$59.0K0.00%
Dark Forest Capital Management LP1,512$8.00K0.00%
Quadrant Capital Group LLC47$00.00%

Sold out (22)

Institutions that held Epizyme, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.